#combination therapy — Thursday, September 24, 2026 (1 items)
| 0 | ℹ |
Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial.
(nature.com)
|
Nature Medicine 2026-09-24 | #clinical trial #immunotherapy #gastric cancer #her2 #combination therapy |